Daito Pharmaceutical Co.,Ltd. (4577.T)
JPY 2025.0
(0.75%)
JPY 2025.0
(0.75%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.18 Billion | 4.15 Billion | 4.37 Billion | 5.18 Billion | 4.3 Billion | 6.88 Billion |
| Net Income | 3.29 Billion | 5.07 Billion | 6.72 Billion | 5.87 Billion | 5.59 Billion | 4.61 Billion |
| Depreciation & Amortization | 3.65 Billion | 3.87 Billion | 3.31 Billion | 3.15 Billion | 2.95 Billion | 2.85 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.17 Billion | -2.32 Billion | -4.39 Billion | -1.58 Billion | -4.22 Billion | 538.36 Million |
| Other non-cash items | 6.33 Billion | -2.46 Billion | -1.26 Billion | -2.26 Billion | -19.18 Million | -1.12 Billion |
| Investing Cash Flow | -5.93 Billion | -5.56 Billion | -4.4 Billion | -6.32 Billion | -2.68 Billion | -3.86 Billion |
| Investments in PPE | -6.27 Billion | -5.55 Billion | -4.73 Billion | -6.34 Billion | -2.77 Billion | -3.66 Billion |
| Acquisitions | - | - | 68 Million | - | -42.13 Million | - |
| Investment purchases | - | - | -68 Million | - | -77.81 Million | -212.37 Million |
| Sales/Maturities of investments | 335 Million | - | 256 Million | 5 Million | 175.27 Million | - |
| Other Investing Activities | 10 Million | -10 Million | 77 Million | 20.28 Million | 36.52 Million | 7.74 Million |
| Financing Cash Flow | -183 Million | 616 Million | 989 Million | 1.42 Billion | -350.46 Million | -2.89 Billion |
| Debt repayment | -1.9 Billion | -1.63 Billion | -1.44 Billion | -1.71 Billion | -1.85 Billion | -2.03 Billion |
| Dividends payments | -907 Million | -931 Million | -660 Million | -658.07 Million | -502.06 Million | -450.74 Million |
| Common Stock Repurchased | -1.17 Billion | -116 Million | 1.49 Billion | -283 Thousand | -188 Thousand | -442 Thousand |
| Common Stock Issuance | - | 308 Million | 1.51 Billion | 1.79 Billion | 2 Billion | -408.4 Million |
| Other Financing Activities | -1 Million | 2.99 Billion | 80 Million | 1.99 Billion | 3.2 Million | -1000.00 |
| Accounts receivables | 2.22 Billion | -1.5 Billion | -3.29 Billion | 2.72 Billion | -3.36 Billion | 947 Million |
| Accounts payables | 802 Million | 538 Million | 22 Million | -765.1 Million | 1.22 Billion | 335.01 Million |
| Inventory | -2.64 Billion | -1.41 Billion | -1.04 Billion | -3.6 Billion | -2.07 Billion | -750.98 Million |
| Other working capital | -1.55 Billion | 51 Million | -81 Million | 68.96 Million | -5.03 Million | 7.33 Million |
| Cash at beginning of period | 3.6 Billion | 4.38 Billion | 3.37 Billion | 3.08 Billion | 1.81 Billion | 1.71 Billion |
| Cash at end of period | 2.72 Billion | 3.6 Billion | 4.38 Billion | 3.37 Billion | 3.08 Billion | 1.81 Billion |
| Capital Expenditure | -6.27 Billion | -5.55 Billion | -4.73 Billion | -6.34 Billion | -2.77 Billion | -3.66 Billion |
| Effect of forex changes on cash | 51 Million | 20 Million | 48 Million | 5.78 Million | -9.69 Million | -14.63 Million |
| Net cash flow / Change in cash | -880 Million | -774 Million | 1 Billion | 288.79 Million | 1.26 Billion | 107.98 Million |
| Free Cash Flow | -1.09 Billion | -1.4 Billion | -363 Million | -1.16 Billion | 1.53 Billion | 3.22 Billion |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.29 Billion | 956 Million | 787 Million | 869 Million | 683 Million | 5.07 Billion |
| Depreciation & Amortization | 3.65 Billion | - | - | 867 Million | 830 Million | 3.87 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.17 Billion | - | - | - | - | -2.32 Billion |
| Other non-cash items | 6.33 Billion | -956 Million | -787 Million | -869 Million | -683 Million | -2.46 Billion |
| Investing Cash Flow | -5.93 Billion | - | - | - | - | -5.56 Billion |
| Investments in PPE | -6.27 Billion | - | - | - | - | -5.55 Billion |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 335 Million | - | - | - | - | - |
| Other Investing Activities | 10 Million | - | - | - | - | -10 Million |
| Financing Cash Flow | -183 Million | - | - | - | - | 616 Million |
| Debt repayment | -1.9 Billion | - | - | - | - | -1.63 Billion |
| Dividends payments | -907 Million | - | - | - | - | -931 Million |
| Common Stock Repurchased | -1.17 Billion | - | - | - | - | -116 Million |
| Common Stock Issuance | - | - | - | - | - | 308 Million |
| Other Financing Activities | -1 Million | - | - | - | - | 2.99 Billion |
| Accounts receivables | 2.22 Billion | - | - | - | - | -1.5 Billion |
| Accounts payables | 802 Million | - | - | - | - | 538 Million |
| Inventory | -2.64 Billion | - | - | - | - | -1.41 Billion |
| Other working capital | -1.55 Billion | - | - | - | - | 51 Million |
| Cash at beginning of period | 3.6 Billion | - | - | 4 Billion | 3.6 Billion | 4.38 Billion |
| Cash at end of period | 2.72 Billion | - | - | 4.58 Billion | 4 Billion | 3.6 Billion |
| Capital Expenditure | -6.27 Billion | - | - | - | - | -5.55 Billion |
| Effect of forex changes on cash | 51 Million | - | - | - | - | 20 Million |
| Net cash flow / Change in cash | -880 Million | - | - | 583 Million | 395 Million | -774 Million |
| Free Cash Flow | -1.09 Billion | - | - | 1.73 Billion | 1.66 Billion | -1.4 Billion |
6237
SPH
NAVINFLUOR
DBOEY
ZDPY
5257